Display options
Cite
Merchan C, Parajuli S, Siegfried J, et al. Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge. Case Rep Infect Dis. 2016;2016:3607125doi: 10.1155/2016/3607125.
Merchan, C., Parajuli, S., Siegfried, J., Scipione, M. R., Dubrovskaya, Y., & Rahimian, J. (2016). Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge. Case reports in infectious diseases, 20163607125. https://doi.org/10.1155/2016/3607125
Merchan, Cristian, et al. "Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge." Case reports in infectious diseases vol. 2016 (2016): 3607125. doi: https://doi.org/10.1155/2016/3607125
Merchan C, Parajuli S, Siegfried J, Scipione MR, Dubrovskaya Y, Rahimian J. Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge. Case Rep Infect Dis. 2016;2016:3607125. doi: 10.1155/2016/3607125. Epub 2016 Jun 23. PMID: 27418986; PMCID: PMC4935919.
Copy Download .nbib Format: NLM
Share it on

Case Rep Infect Dis. 2016;2016:3607125. doi: 10.1155/2016/3607125. Epub 2016 Jun 23.

Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge.

Case reports in infectious diseases

Cristian Merchan, Sunita Parajuli, Justin Siegfried, Marco R Scipione, Yanina Dubrovskaya, Joseph Rahimian

Affiliations

  1. Department of Pharmacy, NYU Langone Medical Center, New York, NY 10016, USA.
  2. Department of Infectious Diseases, NYU Langone Medical Center, New York, NY 10016, USA.

PMID: 27418986 PMCID: PMC4935919 DOI: 10.1155/2016/3607125

Abstract

We describe a case of Bacteroides fragilis bacteremia associated with paraspinal and psoas abscesses in the United States. Resistance to b-lactam/b-lactamase inhibitors, carbapenems, and metronidazole was encountered despite having a recent travel history to India as the only possible risk factor for multidrug resistance. Microbiological cure was achieved with linezolid, moxifloxacin, and cefoxitin.

References

  1. Clin Infect Dis. 2005 Apr 1;40(7):e67-8 - PubMed
  2. Int J Antimicrob Agents. 2015 Jul;46(1):117-20 - PubMed
  3. Clin Infect Dis. 2007 Apr 1;44(7):895-900 - PubMed
  4. J Med Microbiol. 2012 Dec;61(Pt 12):1784-8 - PubMed
  5. J Clin Microbiol. 2006 Sep;44(9):3465-7 - PubMed
  6. Anaerobe. 2015 Feb;31:55-8 - PubMed
  7. Anaerobe. 2011 Aug;17(4):152-5 - PubMed
  8. Lancet. 1995 May 20;345(8960):1275-7 - PubMed
  9. Anaerobe. 2015 Feb;31:4-10 - PubMed
  10. Clin Microbiol Infect. 1999 Mar;5(3):166-169 - PubMed
  11. Clin Microbiol Rev. 2013 Jul;26(3):526-46 - PubMed

Publication Types